Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma

Alain C. Borczuk
European Respiratory Review 2016 25: 364-371; DOI: 10.1183/16000617.0089-2016
Alain C. Borczuk
Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Alb9003@med.cornell.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Imaging and histological correlation in lung adenocarcinoma classification. a) Computed tomography (CT) scan demonstrating a ground-glass nodule that on resection represents adenocarcinoma in situ. b) The preserved alveolar architecture is seen at low magnification in this adenocarcinoma in situ. Scale bar=3 mm. c) CT scan demonstrating a solid area surrounded by a rim of ground-glass attenutation. d) On resection, this was an acinar predominant adenocarcinoma with gland formation seen on the histology image.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Imaging and histological correlation in lung adenocarcinoma classification. a) Computed tomography (CT) scan demonstrating a solid attenuation nodule. b) A micropapillary pattern with small nests of tumours cells surrounded by retraction artefact was seen on the resection specimen. Scale bar=50 μm. c) Papillary pattern is shown with fibrovascular cores and an arborising architecture lined by neoplastic cells. Scale bar=100 μm. d) On the right side a solid tumour nest demonstrating solid pattern adenocarcinoma is seen. A typical feature of lung adenocarcinoma heterogeneity is shown by an adjacent focus on the left showing micropapillary pattern.

Tables

  • Figures
  • TABLE 1

    Studies of predominant histology and outcome: mixed stages

    First author [ref.]5-year survival
    AIS/MIALepidicAcinarPapillarySolidMicropapillary
    DFSDSSOSDFSDSSOSDFSDSSOSDFSDSSOSDFSDSSOSDFSDSSOS
    Murakami [20]1009981827433
    Hung [23]#809090709070709070407060507050
    Tsao [24]#,¶60606055605535453545
    Russell [15]8668713938
    Tsuta [14]989367745862
    Yoshizawa [25]10010099100708167754340042
    Warth [13]738079627967355649516658346045
    Gu [17]10010072915472567246582546
    • AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; DFS: disease-free survival; DSS: disease-specific survival; OS: overall survival. #: data estimated from Kaplan–Meier curves; ¶: papillary/acinar combined, solid/micropapillary combined.

  • TABLE 2

    Studies of predominant histology and outcome: stage I only

    First author [ref.]5-year survival
    AIS/MIALepidicAcinarPapillarySolidMicropapillary
    DFSOSDFSOSDFSOSDFSOSDFSOSDFSOS
    Yang [26]9583926758
    Yoshiya [27]#,¶98988897889764856485
    Yoshizawa [25]1007490758475837570616761
    Hung [23]+>9010080808080607560NA
    • AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; DFS: disease-free survival; OS: overall survival; NA: not available. #: papillary/acinar combined, solid/micropapillary combined; ¶: 3-year survival; +: data estimated from Kaplan–Meier curves.

PreviousNext
Back to top
View this article with LENS
Vol 25 Issue 142 Table of Contents
European Respiratory Review: 25 (142)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma
Alain C. Borczuk
European Respiratory Review Dec 2016, 25 (142) 364-371; DOI: 10.1183/16000617.0089-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma
Alain C. Borczuk
European Respiratory Review Dec 2016, 25 (142) 364-371; DOI: 10.1183/16000617.0089-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The air of Europe: where are we going?
  • Screening for COPD: the gap between logic and evidence
Show more Mini-review: Health and Politics

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society